Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Editas Medicine (EDIT)

Editas Medicine (EDIT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,804,321
  • Shares Outstanding, K 67,363
  • Annual Sales, $ 90,730 K
  • Annual Income, $ -115,980 K
  • 60-Month Beta 2.08
  • Price/Sales 29.96
  • Price/Cash Flow N/A
  • Price/Book 6.43
Trade EDIT with:

Options Overview

Details
  • Implied Volatility 105.73%
  • Historical Volatility 80.09%
  • IV Percentile 69%
  • IV Rank 45.07%
  • IV High 154.71% on 02/01/21
  • IV Low 65.55% on 08/25/20
  • Put/Call Vol Ratio 0.28
  • Today's Volume 2,829
  • Volume Avg (30-Day) 9,034
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 67,278
  • Open Int (30-Day) 67,290

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.76
  • Number of Estimates 6
  • High Estimate -0.67
  • Low Estimate -0.92
  • Prior Year -0.69
  • Growth Rate Est. (year over year) -10.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.10 +12.30%
on 03/05/21
70.06 -42.14%
on 02/09/21
-29.21 (-41.88%)
since 02/08/21
3-Month
36.10 +12.30%
on 03/05/21
99.95 -59.44%
on 01/08/21
-2.64 (-6.11%)
since 12/08/20
52-Week
14.01 +189.36%
on 03/16/20
99.95 -59.44%
on 01/08/21
+16.57 (+69.13%)
since 03/06/20

Most Recent Stories

More News
Editas (EDIT) Misses on Q4 Earnings, Beats on Revenues

Editas (EDIT) reports wider-than-expected loss in the fourth quarter of 2020 while revenues beat estimates. Pipeline development a key focus for the company.

LXRX : 6.74 (-0.59%)
ABBV : 106.11 (-0.55%)
EDIT : 40.54 (-2.62%)
NBRV : 1.7600 (-1.68%)
Editas: 4Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Editas Medicine Inc. (EDIT) on Thursday reported a loss of $62.5 million in its fourth quarter.

EDIT : 40.54 (-2.62%)
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update

Strengthened Leadership by Appointing James (Jim) C. Mullen as President and Chief Executive Officer, and Lisa A. Michaels, M.D., as Chief Medical Officer

EDIT : 40.54 (-2.62%)
Editas Medicine, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Editas Medicine, Inc. (NASDAQ:EDIT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25, 2021...

EDIT : 40.54 (-2.62%)
Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results and Corporate Update

Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Thursday, February 25, 2021, at 8:00 a.m. ET to discuss a corporate...

EDIT : 40.54 (-2.62%)
Editas (EDIT) to Report Q4 Earnings: What's in the Cards?

On Editas' (EDIT) fourth-quarter earnings call, investor focus will be on the company's progress with the development of its CRISPR-based experimental candidate, EDIT-101.

LXRX : 6.74 (-0.59%)
ABBV : 106.11 (-0.55%)
EDIT : 40.54 (-2.62%)
IMVT : 15.39 (+13.92%)
Editas Medicine (EDIT) Outpaces Stock Market Gains: What You Should Know

Editas Medicine (EDIT) closed the most recent trading day at $57.94, moving +1.35% from the previous trading session.

EDIT : 40.54 (-2.62%)
GameStop Lessons: Becoming a Savvy Investor with ETFs

As more young investors take up day trading, I have a recipe for long-term wealth creation

NVDA : 463.73 (-6.97%)
GME : 194.50 (+41.21%)
TSLA : 563.00 (-5.84%)
EDIT : 40.54 (-2.62%)
ARKK : 110.26 (-5.82%)
Bear of the Day: CRISPR Therapeutics (CRSP)

Bear of the Day: CRISPR Therapeutics (CRSP)

NTLA : 46.59 (-10.08%)
EDIT : 40.54 (-2.62%)
CRSP : 113.62 (-0.90%)
ARKK : 110.26 (-5.82%)
ARKG : 81.74 (-3.99%)
5 Best ETFs for Young Investors

As more young investors take up day trading, I have an important recipe for long-term wealth creation.

NVDA : 463.73 (-6.97%)
GME : 194.50 (+41.21%)
TSLA : 563.00 (-5.84%)
EDIT : 40.54 (-2.62%)
ARKK : 110.26 (-5.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Editas Medicine, Inc. is a genome editing company. It focuses on translating its genome editing technology into a novel class of human therapeutics which enable precise and corrective molecular modification to treat diseases. Editas Medicine, Inc. is based in Cambridge, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 48.77
2nd Resistance Point 46.93
1st Resistance Point 43.74
Last Price 40.54
1st Support Level 38.71
2nd Support Level 36.87
3rd Support Level 33.68

See More

52-Week High 99.95
Fibonacci 61.8% 67.12
Fibonacci 50% 56.98
Fibonacci 38.2% 46.84
Last Price 40.54
52-Week Low 14.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar